Evaxion A (EVAX) Return on Invested Capital (2020 - 2026)
Evaxion A's (EVAX) quarterly Return on Invested Capital came in at 0.01% in Q1 2026, little changed YoY from 0.01% in Q1 2025, and down 8.19% on a QoQ basis from 0.01% in Q4 2025.
Evaxion A (EVAX) Return on Invested Capital (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has 7 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Invested Capital retreated to 0.01% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2025 to a low of 0.12% in Q1 2022.
- A 5-year average of 0.03% and a median of 0.02% in 2024 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2022 — Return on Invested Capital surged 1993 bps — and 2025, when it changed 0 bps.
- Tracing EVAX's Return on Invested Capital over 5 years: stood at 0.04% in 2022, then surged by 41 bps to 0.02% in 2023, then surged by 61 bps to 0.01% in 2024, then fell by 4 bps to 0.01% in 2025, then retreated by 8 bps to 0.01% in 2026.
- The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | -0.09% |
| Mar 31, 2022 | -0.12% |
| Dec 31, 2021 | -0.22% |
| Sep 30, 2021 | -4.65% |
| Jun 30, 2021 | -20.03% |